Idience
Developer of oncology drugs intended to deliver breakthroughs that drive innovation and transform cancer treatment. The company's drug is a potent inhibitor that prevents the repair of DNA single-stra...
Valuation
$0
Share Price
N/A
Total Raised
$34.4M
Last Round
N/A